Delivery Order SPE2DB22D1041-SPE2DB25FUBT1
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,275.43 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), an insulin product used in diabetes management. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of NovoLog 100 Unit/ML vial 10ML insulin medication. This is a firm fixed-price delivery order with a ceiling value of $7,929.22 and an ultimate completion date of August 28, 2025. The contract is not set-aside and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of NovoLog 100 Unit/mL vials in 10mL quantities, with a ceiling value of $4,832.32 and a firm fixed price structure. This contract is a non-set-aside award and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $5,309.82 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes treatment. The award was made on September 4, 2025, with a completion date of September 5, 2025, under a firm fixed-price contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of NovoLog 100 Unit/mL Vial 10mL insulin medication with a ceiling value of $1,354.18. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes management. This firm fixed price delivery order, valued at $2,624.10, was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation, and performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $6,102.42 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,424.55. This competitive award, issued under a firm fixed-price delivery order contract type, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The order does not utilize a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,450.65. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, and involves the delivery of insulin...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.90 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL units), an insulin product used in diabetes management. The award, issued on August 21, 2025, with completion targeted for August 22, 2025, utilizes firm fixed pricing with no small business set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its established...